Bottom line
RAGHX vs RYHIX: the short answer
RAGHX (Virtus KAR Health Sciences Fund) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 49% by weight.
But RYHIX is far broader, holding 135 positions to 24 for RAGHX, so beyond the top names it adds exposure RAGHX doesn't have.
RYHIX is cheaper at 1.38% vs 1.41% — a difference of $3.00 a year per $10,000 invested.
Over five years, RYHIX returned +5.1% a year vs +2.4% for RAGHX.
RAGHX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
RAGHX vs RYHIX side by side
| RAGHX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Virtus | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.41% | 1.38% |
| Annual cost per $10k | $141 | $138 |
| 10-yr cost on $10k (prospectus) | $2,148 | $1,709 |
| Max front load | 5.5% | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +1.3% | +14.4% |
| 5-yr return (annualized) | +2.4% | +5.1% |
| 10-yr return (annualized) | +6.2% | +7.9% |
| Best quarter | — | +18.7% |
| Worst quarter | — | −14.4% |
| Net assets (fund) | $91.7M | $19.4M |
| Number of holdings | 24 | 135 |
| Portfolio turnover | 13% | 244% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of RAGHX's top 24 holdings also appear in RYHIX's top 25.
| Holding | RAGHX | RYHIX |
|---|---|---|
| Eli Lilly & Company | 14.84% | 3.63% |
| Abbvie Inc | 5.52% | 2.52% |
| Vertex Pharmaceuticals Inc | 5.32% | 1.34% |
| Merck & Company Inc | 5.06% | 2.04% |
| Unitedhealth Group Inc | 4.65% | 2.22% |
| Mckesson Corp | 4.57% | 1.05% |
| Intuitive Surgical Inc | 3.89% | 1.31% |
| Amgen Inc | 3.85% | 1.56% |
| Thermo Fisher Scientific Inc | 3.65% | 1.61% |
| Danaher Corp | 3.37% | 1.30% |
| Regeneron Pharmaceuticals Inc | 2.90% | 0.90% |
Source: SEC Form N-PORT
RAGHX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between RAGHX and RYHIX?
Which is cheaper, RAGHX or RYHIX?
Should I own both RAGHX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.